Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
出版年份 2021 全文链接
标题
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
作者
关键词
Glioblastoma multiforme, Temozolomide, Drug resistance, O, -methylguanine-DNA methyltransferase (MGMT), Autophagy, Glioma stem cells (GSCs), miRNAs, Combination therapy
出版物
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1876, Issue 2, Pages 188616
出版商
Elsevier BV
发表日期
2021-08-20
DOI
10.1016/j.bbcan.2021.188616
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glioblastoma cell line shows phenotypes of cancer stem cells in hypoxic microenvironment of spheroids
- (2021) Ken Ohnishi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM
- (2021) Viktorija Juric et al. Cells
- NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition
- (2021) Cheng-Yu Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma
- (2021) Rui Gong et al. Experimental Neurobiology
- Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair
- (2020) Fumi Higuchi et al. CLINICAL CANCER RESEARCH
- IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
- (2020) Sue Han et al. BRITISH JOURNAL OF CANCER
- Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol through the Modulation of EGFR and CSC Signaling Pathways
- (2020) Phuong Doan et al. Cells
- Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
- (2020) Can-Bin Fang et al. Frontiers in Cell and Developmental Biology
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
- (2020) Barbara Oldrini et al. Nature Communications
- MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
- (2020) Chengbin Zhao et al. Scientific Reports
- Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma
- (2020) Eun-Jin Yun et al. Cell Death & Disease
- The impact of autophagy during the development and survival of glioblastoma
- (2020) Joanne E. Simpson et al. Open Biology
- Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
- (2020) Yang Liu et al. Biomedicines
- Involvement of N-methylpurine DNA glycosylase in resistance to temozolomide in patient-derived glioma cells
- (2020) Gemma Serrano-Heras et al. Scientific Reports
- The Arabidopsis thaliana Poly(ADP-Ribose) Polymerases 1 and 2 Modify DNA by ADP-Ribosylating Terminal Phosphate Residues
- (2020) Sabira Taipakova et al. Frontiers in Cell and Developmental Biology
- Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice
- (2019) Tonia C. Carter et al. Biomed Research International
- Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
- (2019) Jianxing Yin et al. EBioMedicine
- New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
- (2019) Daniela Criscuolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
- (2019) Guo-zhong Yi et al. BRAIN
- Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
- (2019) Raghupathy Vengoji et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2
- (2019) Wenzheng Luo et al. LIFE SCIENCES
- Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure
- (2019) Marta Guerra-Rebollo et al. Scientific Reports
- C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
- (2019) Zhikuan Yang et al. Frontiers in Oncology
- Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells
- (2019) Zhiyuan Zhu et al. Biomed Research International
- Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
- (2019) Baeza-Kallee et al. Cancers
- Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery
- (2019) Lystad et al. Cells
- Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
- (2019) Olivia G. Taylor et al. Frontiers in Oncology
- Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway
- (2019) Xiao Yu et al. LIFE SCIENCES
- RDNA-12. THE FANCONI ANAEMIA (FA) PATHWAY AND GLIOBLASTOMA: A NEW FOUNDATION FOR DNA DAMAGE RESPONSE TARGETED COMBINATIONS
- (2019) Ola Rominiyi et al. NEURO-ONCOLOGY
- Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma
- (2019) Qiong Wu et al. Scientific Reports
- Targeting autophagy-related protein kinases for potential therapeutic purpose
- (2019) Honggang Xiang et al. Acta Pharmaceutica Sinica B
- Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide
- (2019) Jinglin Guo et al. CELL BIOCHEMISTRY AND FUNCTION
- IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma
- (2019) G. Guo et al. Clinical & Translational Oncology
- SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT
- (2019) Chia-Kuang Tsai et al. FASEB JOURNAL
- Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin
- (2019) Dennis S. Metselaar et al. EBioMedicine
- Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma
- (2018) Quanye Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
- (2018) Zhiyun Yu et al. CANCER LETTERS
- miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway
- (2018) Hong Li et al. Journal of Hematology & Oncology
- Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma
- (2018) Wen-Bin Yang et al. MOLECULAR NEUROBIOLOGY
- Temozolomide-associated hypermutation in gliomas
- (2018) Serah Choi et al. NEURO-ONCOLOGY
- Wild-type and mutated IDH1/2 enzymes and therapy responses
- (2018) Remco J. Molenaar et al. ONCOGENE
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
- (2018) Xin Zhang et al. Cell Death & Disease
- PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
- (2018) George E. Ronson et al. Nature Communications
- Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
- (2018) Abigail Kora Suwala et al. Oncotarget
- Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells
- (2018) Seyed Abbas Mirzaei et al. Scientific Reports
- Current Strategies for Brain Drug Delivery
- (2018) Xiaowei Dong Theranostics
- MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
- (2018) Yi-Yen Lee et al. Cancer Management and Research
- Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
- (2018) Bianca Maria Scicchitano et al. Cancer Cell International
- Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells
- (2018) Biao Yang et al. CANCER GENE THERAPY
- β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species
- (2018) Yiming Bi et al. CANCER LETTERS
- Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma
- (2018) Iris C. Salaroglio et al. MOLECULAR CANCER THERAPEUTICS
- MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
- (2018) Alireza Mansouri et al. NEURO-ONCOLOGY
- Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
- (2018) Shabierjiang JIAPAER et al. NEUROLOGIA MEDICO-CHIRURGICA
- Isofuranodiene synergizes with Temozolomide in inducing glioma cells death
- (2018) Alessandra Brunetti et al. PHYTOMEDICINE
- Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
- (2018) Mariachiara Buccarelli et al. Cell Death & Disease
- SOX3 can promote the malignant behavior of glioblastoma cells
- (2018) Jelena Marjanovic Vicentic et al. CELLULAR ONCOLOGY
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
- (2018) Amanda L. Hudson et al. Frontiers in Oncology
- Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway
- (2018) Peng Zhang et al. BIOSCIENCE REPORTS
- Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway
- (2018) Yiming Bi et al. MOLECULAR PHARMACEUTICS
- Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1–SOX2 positive-feedback loop
- (2018) Jun Wang et al. NATURE NEUROSCIENCE
- Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
- (2018) Iwona Anna Ciechomska et al. Frontiers in Pharmacology
- Autophagy: An Essential Degradation Program for Cellular Homeostasis and Life
- (2018) Yoomi Chun et al. Cells
- MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma
- (2017) Zhen-Xiu Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Stage-specific embryonic antigen: determining expression in canine glioblastoma, melanoma, and mammary cancer cells
- (2017) Weiming Lin et al. Journal of Veterinary Science
- CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide
- (2017) Simran Kaur et al. NEURO-ONCOLOGY
- Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma
- (2017) Qiang Li et al. Oncology Letters
- Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
- (2017) Silvia Valtorta et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma
- (2017) Thomas Ströbel et al. Scientific Reports
- Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O 6 -methylguanine-DNA methyltransferase
- (2017) Kwang-Yu Chang et al. Redox Biology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways
- (2016) YiHan Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues
- (2016) Jin Xu et al. ENDOCRINE PATHOLOGY
- mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
- (2016) Laura Garros-Regulez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different kinds of anticancer drugs
- (2016) Jin-Ming Li et al. International Journal of Nanomedicine
- A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
- (2016) Giulia Regazzo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors
- (2016) Jeanette Krogh Petersen et al. PLoS One
- MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
- (2016) Tian Tian et al. Oncotarget
- Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
- (2016) Yong-tao Gao et al. Scientific Reports
- The emerging roles of Oct4 in tumor-initiating cells
- (2015) Ying-Jie Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines
- (2015) Joana Balça-Silva et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
- (2015) Dawn Q Chong et al. BMC CANCER
- LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2
- (2015) Baohui Liu et al. BRAIN RESEARCH
- The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells
- (2015) Seung Woo Lee et al. CANCER LETTERS
- Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide
- (2015) J. L. McFaline-Figueroa et al. CANCER RESEARCH
- ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
- (2015) Rutger K Balvers et al. Journal of Translational Medicine
- Isolation and characteristics of CD133−/A2B5+ and CD133−/A2B5− cells from the SHG139s cell line
- (2015) YONG HAN et al. Molecular Medicine Reports
- APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line
- (2015) Ana P. Montaldi et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo
- (2015) R Auvergne et al. ONCOGENE
- miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells
- (2015) ZHIWU WU et al. ONCOLOGY REPORTS
- Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation
- (2015) KERRIE L. MCDONALD et al. Oncology Letters
- Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
- (2015) Jessian L. Munoz et al. Oncotarget
- Gap junctions modulate glioma invasion by direct transfer of microRNA
- (2015) Xiaoting Hong et al. Oncotarget
- IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
- (2015) Pei Yang et al. Oncotarget
- Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
- (2015) Gloria Perazzoli et al. PLoS One
- Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity
- (2015) Swapna Asuthkar et al. Oncotarget
- Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
- (2015) Yoshinari Shinsato et al. Oncotarget
- EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
- (2015) Lotte Hiddingh et al. Oncotarget
- FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents
- (2015) Abhijit A. Patil et al. Oncotarget
- A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas
- (2015) Deepa Kushwaha et al. Oncotarget
- IDH1 Overexpression Induced Chemotherapy Resistance and IDH1 Mutation Enhanced Chemotherapy Sensitivity in Glioma Cells in Vitro and in Vivo
- (2014) Ju-Bo Wang et al. Asian Pacific Journal of Cancer Prevention
- Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
- (2014) Lucio Tentori et al. BMC CANCER
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells
- (2014) Yusuke S. Hori et al. JOURNAL OF NEURO-ONCOLOGY
- Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth
- (2014) Y. P. Ramirez et al. MOLECULAR CANCER THERAPEUTICS
- Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma
- (2014) YUHUI ZOU et al. Molecular Medicine Reports
- VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
- (2014) Yuanyuan Chen et al. NEURO-ONCOLOGY
- Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy
- (2014) Encouse B. Golden et al. Neurosurgical Focus
- Correction: FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ
- (2014) Natsuko Kondo et al. PLoS One
- An Overview of Autophagy: Morphology, Mechanism, and Regulation
- (2013) Katherine R. Parzych et al. ANTIOXIDANTS & REDOX SIGNALING
- microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells
- (2013) Sergio Comincini et al. CANCER BIOLOGY & THERAPY
- Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks
- (2013) C. Shen et al. CANCER RESEARCH
- The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas
- (2013) Hailin Tang et al. CURRENT CANCER DRUG TARGETS
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Current views on the source of the autophagosome membrane
- (2013) Sharon A. Tooze Essays in Biochemistry
- Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies
- (2013) Atique U Ahmed et al. Expert Review of Neurotherapeutics
- Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma
- (2013) JUNHYE KWON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Using the molecular classification of glioblastoma to inform personalized treatment
- (2013) Adriana Olar et al. JOURNAL OF PATHOLOGY
- Base Excision Repair
- (2013) H. E. Krokan et al. Cold Spring Harbor Perspectives in Biology
- O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
- (2013) C-H Fan et al. Cell Death & Disease
- Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
- (2013) Zhi-Kun Qiu et al. Chinese Journal of Cancer
- Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
- (2013) Jessian L Munoz et al. Molecular Therapy-Nucleic Acids
- Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
- (2012) H. Kim et al. GENES & DEVELOPMENT
- MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug Temozolomide
- (2012) Shuguang Zhang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
- (2012) Annette Håvik et al. Journal of Translational Medicine
- MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
- (2012) Consolación Melguizo et al. Journal of Translational Medicine
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- MicroRNAs in Human Malignant Gliomas
- (2012) Masahiro Mizoguchi et al. Journal of Oncology
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
- (2012) Koji Yoshimoto et al. Frontiers in Oncology
- Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
- (2011) Yi-Ping Yang et al. BIOMATERIALS
- Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines
- (2011) M Z Mohammed et al. BRITISH JOURNAL OF CANCER
- Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
- (2011) E. M. Goellner et al. CANCER RESEARCH
- DNA glycosylases: in DNA repair and beyond
- (2011) Angelika L. Jacobs et al. CHROMOSOMA
- Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
- (2011) Sameer Agnihotri et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
- (2011) Minfeng Shu et al. Molecular Cancer
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
- (2011) S. Torres et al. MOLECULAR CANCER THERAPEUTICS
- N-methylpurine DNA glycosylase and DNA polymerase β modulate BER inhibitor potentiation of glioma cells to temozolomide
- (2011) Jiang-bo Tang et al. NEURO-ONCOLOGY
- Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
- (2011) Nameeta Shah et al. PLoS One
- A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
- (2011) Sujaya Srinivasan et al. PLoS One
- MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
- (2010) Lei Shi et al. BRAIN RESEARCH
- miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
- (2010) Kenta Ujifuku et al. CANCER LETTERS
- Overview of macroautophagy regulation in mammalian cells
- (2010) Maryam Mehrpour et al. CELL RESEARCH
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
- (2010) Marc C Chamberlain Expert Review of Neurotherapeutics
- Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide
- (2010) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- Radiation Resistance in Glioma Cells Determined by DNA Damage Repair Activity of Ape1/Ref-1
- (2010) Mamta D. NAIDU et al. JOURNAL OF RADIATION RESEARCH
- A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
- (2009) Aurélie Tchoghandjian et al. BRAIN PATHOLOGY
- Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
- (2009) Tracy-Ann Read et al. CANCER CELL
- MicroRNAs and glioblastoma; the stem cell connection
- (2009) J Godlewski et al. CELL DEATH AND DIFFERENTIATION
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
- (2009) S. Yip et al. CLINICAL CANCER RESEARCH
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- O6-Methylguanine-DNA methyltransferase inactivation and chemotherapy
- (2008) B. Verbeek et al. BRITISH MEDICAL BULLETIN
- Cell Cycle-Dependent Variation of a CD133 Epitope in Human Embryonic Stem Cell, Colon Cancer, and Melanoma Cell Lines
- (2008) M. Jaksch et al. CANCER RESEARCH
- MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
- (2008) T. Papagiannakopoulos et al. CANCER RESEARCH
- Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs
- (2008) Wynand P. Roos et al. DNA REPAIR
- Oct4 is expressed in human gliomas and promotes colony formation in glioma cells
- (2008) Zhanhui Du et al. GLIA
- Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
- (2008) Gaspar J. Kitange et al. JOURNAL OF NEURO-ONCOLOGY
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
- (2008) Gaspar J. Kitange et al. NEURO-ONCOLOGY
- IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
- (2008) Alfred T. Ogden et al. NEUROSURGERY
- CD133 Is a Marker of Bioenergetic Stress in Human Glioma
- (2008) Corinne E. Griguer et al. PLoS One
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started